搜索
Creative Medical Technology Holdings Inc
CELZ添加自选
2.240USD
0.0000.00%
收盘 05/15, 16:00（美东）报价延迟15分钟
8.28M总市值
亏损市盈率 TTM
关于 Creative Medical Technology Holdings Inc 公司
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc简介
公司代码CELZ
公司名称Creative Medical Technology Holdings Inc
上市日期May 01, 2009
CEOWarbington (Timothy)
员工数量4
证券类型Ordinary Share
年结日May 01
公司地址211 E. Osborn Rd.
城市PHOENIX
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编85012
电话14803992822
网址https://creativemedicaltechnology.com/
公司代码CELZ
上市日期May 01, 2009
CEOWarbington (Timothy)
Creative Medical Technology Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
Geode Capital Management, L.L.C.
0.77%
Creative Medical Health, Inc.
0.61%
Vanguard Capital Management, LLC
0.55%
Citadel Advisors LLC
0.47%
Warbington (Timothy)
0.33%
其他
97.26%
持股股东
持股股东
占比
Geode Capital Management, L.L.C.
0.77%
Creative Medical Health, Inc.
0.61%
Vanguard Capital Management, LLC
0.55%
Citadel Advisors LLC
0.47%
Warbington (Timothy)
0.33%
其他
97.26%
股东类型
持股股东
占比
Investment Advisor
1.22%
Research Firm
0.96%
Investment Advisor/Hedge Fund
0.77%
Corporation
0.61%
Hedge Fund
0.53%
Individual Investor
0.34%
其他
95.56%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
29
128.85K
3.49%
-193.41K
2025Q4
27
72.58K
11.84%
--
2025Q3
29
72.58K
11.88%
+776.00
2025Q2
25
71.80K
10.72%
-129.79K
2025Q1
23
201.59K
4.41%
+89.66K
2024Q4
25
29.86K
7.67%
-49.38K
2024Q3
28
77.15K
11.92%
-653.00
2024Q2
30
77.93K
20.77%
-35.91K
2024Q1
32
113.90K
14.79%
-86.68K
2023Q4
34
27.41K
16.84%
+6.21K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Geode Capital Management, L.L.C.
28.47K
0.77%
+5.21K
+22.41%
Dec 31, 2025
Creative Medical Health, Inc.
22.70K
0.61%
--
--
Oct 29, 2025
Citadel Advisors LLC
17.46K
0.47%
+17.46K
--
Dec 31, 2025
Warbington (Timothy)
12.21K
0.33%
--
--
Oct 29, 2025
DRW Securities, LLC
10.32K
0.28%
-4.78K
-31.67%
Dec 31, 2025
Global Retirement Partners, LLC
7.92K
0.21%
+7.92K
--
Dec 31, 2025
BofA Global Research (US)
5.13K
0.14%
+5.00K
+3817.56%
Dec 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
公告日期
除权除息日
类型
比率
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
